E-cigarette - CSS 2 experts paid by companies selling nicotine replacement

( Belga ) Two of the six experts who signed the recent opinion of the Supreme Council of Health ( CSS) reluctant to electronic cigarettes were paid by pharmaceutical companies that market nicotine replacement or lucrative drugs against lung cancer , reports the weekly Marianne .


E- cigarette - CSS 2 experts paid by companies selling nicotine replacement
Published on December 11 , the opinion of CSS issued a " reluctance " to " general availability " of the product . According to Marianne , two of the six experts who signed this notice has had recent ties to the pharmaceutical industry. The first and said he was " speaker -time " paid to Janssen ( 2011 ) and Eli Lilly ( 2010 and 2011 ) . Janssen famous gold markets Nicorette , a range of nicotine replacement , and Eli Lilly sells drugs to treat lung cancer that are " 50 times more generating revenue that drug aid against smoking " according to a French consultant in tobacco . The second expert pointed by the weekly is , since 2006, paid by Pfizer Varenicline consultant, the active ingredient in Champix - the most expensive substitutes in the treatment of smoking. In 2008-2009, he oversaw an observational study funded by Pfizer product and , between 2010 and 2012 , he coordinated a clinical study of this drug , also sponsored by Pfizer. "The issue , according to our expert evaluation working group, showed no potential conflict of interests," concludes however Sandrine Everaert , Quality Manager at CSS. After having read the article Mariannne , the Belgian association " vapoteurs " or the users of the e-cigarette, is seeking " a real assessment of the phenomenon of electronic cigarette and , by an entity independent of any conflict of interest, " she said Sunday in a statement. vapor cigarette wholesale